[유상증자 모니터] 루닛, '빅5 VC' 유치…핵심은 CB·유동성 방어

Lunit's 211 billion won equity raise prioritizes debt repayment over growth investments, exposing the financial toll of its 2024 Volpara acquisition. Atnum Investment's participation as a major VC signals confidence in the company's medical AI capabilities, while the capital infusion targets convertible bond obligations and liquidity stabilization rather than R&D expansion or aggressive market expansion.